Survivin expression in cardiac myxoma

Chang Gung Medical Journal

Volumn 34, Issue 4, 2011, Pages 360-366

  Lin, Yu Sheng ^a   Jung, Shih Ming ^a   Wu, Hsueh Hwa ^a   Shiu, Tzu Fang ^a   Tzai, Feng Chun ^a   Chu, Jaw Ji ^a   Lin, Pyng Jing ^a   Chu, Pao Hsien ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Apoptosis; Cardiac myxoma; Survivin

Indexed keywords

HEMOGLOBIN; SURVIVIN;

ADULT; ANEMIA; APOPTOSIS; ARTICLE; CALCIFICATION; CANCER SURGERY; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; DYSPNEA; FEMALE; FEVER; HEART LEFT ATRIUM; HEART MYXOMA; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MITRAL VALVE REGURGITATION; MORPHOLOGY; PATHOGENESIS; PROTEIN EXPRESSION; STROKE; THORAX PAIN; THROMBOSIS; TRICUSPID VALVE REGURGITATION; TUMOR VOLUME;

ADULT; FEMALE; HEART NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; MYXOMA;

EID: 80052648038     PISSN: 20720939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 1998;58:5315-20.
2. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21.
3. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396:580-4.
4. Chu JS, Shew JY, Huang CS. Immunohistochemical analysis of survivin expression in primary breast cancers. J Formos Med Assoc 2004;103:925-31.
5. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer, Cancer Res 1998;58:5071-4.
6. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 2000;46:645-50.
7. Sarela AI, Scott N, Ramsdale J, Markham AF, Guillou PJ. Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol 2001;8:305-10.
8. Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998;58:1808-12.
9. Koike H, Sekine Y, Kamiya M, Nakazato H, Suzuki K. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer. Urology 2008;72:1229-33.
10. Grossman D, McNiff JM, Li F, Altieri DC. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 1999;113:1076-81.
11. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC, Molina TJ. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 2000;96:1921-5.
12. Li F, Ling X. Survivin study: an update of "what is the next wave"? J Cell Physiol 2006;208:476-86.
13. Andersen MH, Svane IM, Becker JC, Straten PT. The universal character of the tumor-associated antigen survivin. Clin Cancer Res 2007;13:5991-4.
14. Kang PM, Yue P, Izumo S. New insights into the role of apoptosis in cardiovascular disease. Circ J 2002;66:1-9.
15. Chu PH, Jung SM, Wu HH, Chien LY, Hsueh C, Chu JJ, Lee YS. Apoptosis in primary cardiac tumours. Int J Clin Pract 2004;58:564-7.
16. Suzuki M, Hamada M, Hiwada K. Apoptosis in cardiac myxoma. Ann Intern Med 2000;132:681.
17. Hofstra L, Dumont EA, Thimister PW, Heidendal GA, DeBruine AP, Elenbaas TW, Boersma HH, van Heerde WL, Reutelingsperger CP. In vivo detection of apoptosis in an intracardiac tumor. JAMA 2001;285:1841-2.
18. Burke AP, Virmani R. Cardiac myxoma. A clinicopathologic study. Am J Clin Pathol 1993;100:671-80.
19. Reynen K. Cardiac myxomas. N Engl J Med 1995;333:1610-7.
20. Pucci A, Gagliardotto P, Zanini C, Pansini S, di Summa M, Mollo F. Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J 2000;140:134-8.
21. Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore) 2001;80:159-72.
22. Acebo E, Val-Bernal JF, Gomez-Roman JJ, Revuelta JM. Clinicopathologic study and DNA analysis of 37 cardiac myxomas: a 28-year experience. Chest 2003;123:1379-5.
23. Terracciano LM, Mhawech P, Suess K, D'Armiento M, Lehmann FS, Jundt G, Moch H, Sauter G, Mihatsch MJ. Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am J Clin Pathol 2000;114:754-9.
24. Deshpande A, Venugopal P, Kumar AS, Chopra P. Phenotypic characterization of cellular components of cardiac myxoma: a light microscopy and immunohistochemistry study. Hum Pathol 1996;27:1056-9.
25. Goldman BI, Frydman C, Harpaz N, Ryan SF, Loiterman D. Glandular cardiac myxomas. Histologic, immunohistochemical, and ultrastructural evidence of epithelial differentiation. Cancer 1987;59:1767-75.
26. Chu PH, Jung SM, Yeh CH, Yeh TS, Wang CL. Mucin gene expression in cardiac myxoma. Int J Clin Pract 2004;58:306-9.
27. Chu PH, Jung SM, Yeh TS, Lin HC, Chu JJ. MUC1, MUC2 and MUC5AC expressions in cardiac myxoma. Virchows Arch 2005;446:52-5.